Titre : Désalkylation

Désalkylation : Questions médicales fréquentes

Termes MeSH sélectionnés :

Data Interpretation, Statistical
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Désalkylation : Questions médicales les plus fréquentes", "headline": "Désalkylation : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Désalkylation : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-28", "dateModified": "2025-02-22", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Désalkylation" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Métabolisme", "url": "https://questionsmedicales.fr/mesh/D008660", "about": { "@type": "MedicalCondition", "name": "Métabolisme", "code": { "@type": "MedicalCode", "code": "D008660", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G03" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Déméthylation", "alternateName": "Demethylation", "url": "https://questionsmedicales.fr/mesh/D000073398", "about": { "@type": "MedicalCondition", "name": "Déméthylation", "code": { "@type": "MedicalCode", "code": "D000073398", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G03.219.500" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Déméthylation de l'ADN", "alternateName": "DNA Demethylation", "url": "https://questionsmedicales.fr/mesh/D000073399", "about": { "@type": "MedicalCondition", "name": "Déméthylation de l'ADN", "code": { "@type": "MedicalCode", "code": "D000073399", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G03.219.500.500" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Désalkylation", "alternateName": "Dealkylation", "code": { "@type": "MedicalCode", "code": "D003640", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Michael R Baldwin", "url": "https://questionsmedicales.fr/author/Michael%20R%20Baldwin", "affiliation": { "@type": "Organization", "name": "Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan 48109-0600." } }, { "@type": "Person", "name": "Suzanne J Admiraal", "url": "https://questionsmedicales.fr/author/Suzanne%20J%20Admiraal", "affiliation": { "@type": "Organization", "name": "Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan 48109-0600." } }, { "@type": "Person", "name": "Patrick J O'Brien", "url": "https://questionsmedicales.fr/author/Patrick%20J%20O%27Brien", "affiliation": { "@type": "Organization", "name": "Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan 48109-0600. Electronic address: pjobrien@umich.edu." } }, { "@type": "Person", "name": "Yusuke Suzuki", "url": "https://questionsmedicales.fr/author/Yusuke%20Suzuki", "affiliation": { "@type": "Organization", "name": "Department of Hospital Pharmacy, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Shizuoka, 431-3192, Japan." } }, { "@type": "Person", "name": "Takafumi Naito", "url": "https://questionsmedicales.fr/author/Takafumi%20Naito", "affiliation": { "@type": "Organization", "name": "Department of Hospital Pharmacy, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Shizuoka, 431-3192, Japan. naitou@shinshu-u.ac.jp." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Low-density lipoprotein cholesterol in adolescents and young adults with type 1 diabetes: Data from the Australasian Diabetes Data Network registry.", "datePublished": "2023-07-27", "url": "https://questionsmedicales.fr/article/37467116", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/dme.15184" } }, { "@type": "ScholarlyArticle", "name": "A New Strategy for Evaluating the Quality of Laboratory Results for Big Data Research: Using External Quality Assessment Survey Data (2010-2020).", "datePublished": "2023-04-21", "url": "https://questionsmedicales.fr/article/37080743", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3343/alm.2023.43.5.425" } }, { "@type": "ScholarlyArticle", "name": "Examination of validity of identifying congenital heart disease from hospital discharge data without a gold standard: Using a data linkage approach.", "datePublished": "2023-03-29", "url": "https://questionsmedicales.fr/article/36991572", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/ppe.12976" } }, { "@type": "ScholarlyArticle", "name": "The handling of missing data in trial-based economic evaluations: should data be multiply imputed prior to longitudinal linear mixed-model analyses?", "datePublished": "2022-09-26", "url": "https://questionsmedicales.fr/article/36161553", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10198-022-01525-y" } }, { "@type": "ScholarlyArticle", "name": "Issues With Variability in Electronic Health Record Data About Race and Ethnicity: Descriptive Analysis of the National COVID Cohort Collaborative Data Enclave.", "datePublished": "2022-09-06", "url": "https://questionsmedicales.fr/article/35917481", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2196/39235" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Métabolisme", "item": "https://questionsmedicales.fr/mesh/D008660" }, { "@type": "ListItem", "position": 3, "name": "Désalkylation", "item": "https://questionsmedicales.fr/mesh/D003640" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Désalkylation - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Désalkylation", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Désalkylation", "description": "Comment diagnostiquer une désalkylation ?\nQuels tests sont utilisés pour la désalkylation ?\nQuels signes indiquent une désalkylation ?\nLa désalkylation est-elle détectable par imagerie ?\nQuels marqueurs sont associés à la désalkylation ?", "url": "https://questionsmedicales.fr/mesh/D003640?mesh_terms=Data+Interpretation,+Statistical&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Désalkylation", "description": "Quels symptômes sont liés à la désalkylation ?\nLa désalkylation provoque-t-elle des effets neurologiques ?\nY a-t-il des symptômes cutanés associés ?\nLa désalkylation affecte-t-elle le foie ?\nQuels signes de toxicité sont observés ?", "url": "https://questionsmedicales.fr/mesh/D003640?mesh_terms=Data+Interpretation,+Statistical&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Désalkylation", "description": "Comment prévenir la désalkylation ?\nLes contrôles médicaux aident-ils à prévenir la désalkylation ?\nL'éducation des patients est-elle importante ?\nLes changements de mode de vie aident-ils ?\nLes professionnels de santé jouent-ils un rôle ?", "url": "https://questionsmedicales.fr/mesh/D003640?mesh_terms=Data+Interpretation,+Statistical&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Désalkylation", "description": "Quel traitement pour une désalkylation toxique ?\nLes médicaments peuvent-ils aider à la désalkylation ?\nComment gérer les symptômes de désalkylation ?\nY a-t-il des traitements préventifs ?\nLa désalkylation nécessite-t-elle une hospitalisation ?", "url": "https://questionsmedicales.fr/mesh/D003640?mesh_terms=Data+Interpretation,+Statistical&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Désalkylation", "description": "Quelles complications peuvent survenir ?\nLa désalkylation peut-elle entraîner des maladies chroniques ?\nY a-t-il des risques de surdosage ?\nLes complications sont-elles réversibles ?\nComment surveiller les complications ?", "url": "https://questionsmedicales.fr/mesh/D003640?mesh_terms=Data+Interpretation,+Statistical&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Désalkylation", "description": "Quels sont les facteurs de risque de désalkylation ?\nL'âge influence-t-il le risque de désalkylation ?\nLes habitudes alimentaires affectent-elles le risque ?\nLe tabagisme est-il un facteur de risque ?\nLes maladies préexistantes influencent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D003640?mesh_terms=Data+Interpretation,+Statistical&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une désalkylation ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests biochimiques et des analyses de sang pour évaluer les métabolites." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour la désalkylation ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de toxicologie et des analyses enzymatiques sont couramment utilisés." } }, { "@type": "Question", "name": "Quels signes indiquent une désalkylation ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des signes cliniques comme des anomalies hépatiques peuvent indiquer une désalkylation." } }, { "@type": "Question", "name": "La désalkylation est-elle détectable par imagerie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Non, la désalkylation est généralement évaluée par des tests biochimiques, pas par imagerie." } }, { "@type": "Question", "name": "Quels marqueurs sont associés à la désalkylation ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les marqueurs comme les enzymes hépatiques peuvent être augmentés lors de la désalkylation." } }, { "@type": "Question", "name": "Quels symptômes sont liés à la désalkylation ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent inclure des nausées, des vomissements et des douleurs abdominales." } }, { "@type": "Question", "name": "La désalkylation provoque-t-elle des effets neurologiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets neurologiques comme des vertiges peuvent survenir en cas de désalkylation." } }, { "@type": "Question", "name": "Y a-t-il des symptômes cutanés associés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des éruptions cutanées peuvent apparaître en raison de réactions aux métabolites de désalkylation." } }, { "@type": "Question", "name": "La désalkylation affecte-t-elle le foie ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraîner des anomalies hépatiques et une hépatotoxicité." } }, { "@type": "Question", "name": "Quels signes de toxicité sont observés ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des signes de toxicité incluent fatigue, confusion et jaunisse dans les cas graves." } }, { "@type": "Question", "name": "Comment prévenir la désalkylation ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter l'exposition à des substances chimiques et suivre les prescriptions médicales aide." } }, { "@type": "Question", "name": "Les contrôles médicaux aident-ils à prévenir la désalkylation ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des contrôles réguliers peuvent détecter des problèmes avant qu'ils ne deviennent graves." } }, { "@type": "Question", "name": "L'éducation des patients est-elle importante ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, informer les patients sur les risques des médicaments et des toxines est crucial." } }, { "@type": "Question", "name": "Les changements de mode de vie aident-ils ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Adopter un mode de vie sain peut réduire le risque de désalkylation et de complications." } }, { "@type": "Question", "name": "Les professionnels de santé jouent-ils un rôle ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les professionnels de santé doivent surveiller les interactions médicamenteuses et les risques." } }, { "@type": "Question", "name": "Quel traitement pour une désalkylation toxique ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement peut inclure des soins de soutien et des antidotes spécifiques selon le toxique." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider à la désalkylation ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments peuvent faciliter le métabolisme et l'élimination des toxines." } }, { "@type": "Question", "name": "Comment gérer les symptômes de désalkylation ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La gestion des symptômes inclut des antiémétiques et des analgésiques pour le confort." } }, { "@type": "Question", "name": "Y a-t-il des traitements préventifs ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les substances toxiques et surveiller les médicaments peut prévenir la désalkylation." } }, { "@type": "Question", "name": "La désalkylation nécessite-t-elle une hospitalisation ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Cela dépend de la gravité des symptômes et de l'exposition aux toxines, parfois nécessaire." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des lésions hépatiques, des troubles neurologiques et des réactions allergiques." } }, { "@type": "Question", "name": "La désalkylation peut-elle entraîner des maladies chroniques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une désalkylation sévère peut contribuer à des maladies chroniques comme la cirrhose." } }, { "@type": "Question", "name": "Y a-t-il des risques de surdosage ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un surdosage de substances pouvant subir désalkylation peut être fatal." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles avec un traitement précoce, d'autres non." } }, { "@type": "Question", "name": "Comment surveiller les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "La surveillance clinique et les tests de laboratoire réguliers sont essentiels pour détecter les complications." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de désalkylation ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'exposition à des toxines, l'usage de certains médicaments et des antécédents hépatiques." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque de désalkylation ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent avoir un risque accru en raison d'une fonction hépatique diminuée." } }, { "@type": "Question", "name": "Les habitudes alimentaires affectent-elles le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en toxines ou en médicaments peut augmenter le risque de désalkylation." } }, { "@type": "Question", "name": "Le tabagisme est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut augmenter le risque de désalkylation en raison de l'exposition à des substances nocives." } }, { "@type": "Question", "name": "Les maladies préexistantes influencent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme l'hépatite ou la cirrhose augmentent le risque de désalkylation." } } ] } ] }

Sources (10000 au total)

Low-density lipoprotein cholesterol in adolescents and young adults with type 1 diabetes: Data from the Australasian Diabetes Data Network registry.

To determine low-density lipoprotein cholesterol (LDL-C) screening frequency and levels, and factors associated with elevated LDL-C, in Australasian youth with type 1 diabetes (T1D).... Data were extracted from the Australasian Diabetes Data Network (ADDN), a prospective clinical quality registry, on all T1D healthcare visits attended by young people aged 16-25 years (with T1D durati... A cohort of 6338 young people (52.6% men) were identified, of whom 1603 (25.3%) had ≥1 LDL-C measurement documented. At last measurement, mean age, age at T1D diagnosis and T1D duration were 18.3 ± 2.... LDL-C screening and levels are suboptimal in this cohort, increasing future cardiovascular complication risk. There is an urgent need to understand how healthcare services can support improved screeni...

A New Strategy for Evaluating the Quality of Laboratory Results for Big Data Research: Using External Quality Assessment Survey Data (2010-2020).

To ensure valid results of big data research in the medical field, the input laboratory results need to be of high quality. We aimed to establish a strategy for evaluating the quality of laboratory re... We used Korean Association of External Quality Assessment Service (KEQAS) data to retrospectively review multicenter data. Seven measurands were analyzed using commutable materials: HbA1c, creatinine ... The acceptance rate (22.5%-100%) varied greatly among the test items, and the mean percentage biases were 0.6%-5.6%, 1.0%-9.6%, and 1.6%-11.3% for all items that satisfied optimum, desirable, and mini... The acceptance rate of participants and their external quality assessment (EQA) results exhibited statistically significant differences according to the quality grade for each criterion. Even when the...

Examination of validity of identifying congenital heart disease from hospital discharge data without a gold standard: Using a data linkage approach.

Administrative health data has been used extensively to examine congenital heart disease (CHD). However, the accuracy and completeness of these data must be assessed.... To use data linkage of multiple administrative data sources to examine the validity of identifying CHD cases recorded in hospital discharge data.... We identified all liveborn infants born 2013-2017 in New South Wales, Australia with a CHD diagnosis up to age one, recorded in hospital discharge data. Using record linkage to multiple data sources, ... Of 485,239 liveborn infants, there were 4043 infants with a CHD diagnosis identified in hospital discharge data (8.3 per 1000 live births). The PPV for any CHD identified in any of the five methods wa... Using data linkage of multiple datasets is a novel and cost-effective method to examine the validity of CHD diagnoses recorded in one dataset. These results can be incorporated into bias analyses in f...

The handling of missing data in trial-based economic evaluations: should data be multiply imputed prior to longitudinal linear mixed-model analyses?

For the analysis of clinical effects, multiple imputation (MI) of missing data were shown to be unnecessary when using longitudinal linear mixed-models (LLM). It remains unclear whether this also appl... Two-thousand complete datasets were simulated containing five time points. Incomplete datasets were generated with 10, 25, and 50% missing data in follow-up costs and effects, assuming a Missing At Ra... For costs and effects, LLM, MI-LLM, and MI-SUR performed better than M-LLM, SUR-CCA, and M-SUR, with smaller EBs and RMSEs as well as CRs closers to nominal levels. However, even though LLM, MI-LLM an... LLM should be combined with MI when analyzing trial-based economic evaluation data. MI-SUR is more efficient and can also be used, but then an average intervention effect over time cannot be estimated...

Issues With Variability in Electronic Health Record Data About Race and Ethnicity: Descriptive Analysis of the National COVID Cohort Collaborative Data Enclave.

The adverse impact of COVID-19 on marginalized and under-resourced communities of color has highlighted the need for accurate, comprehensive race and ethnicity data. However, a significant technical c... This study aims to evaluate and describe variations in how health care systems collect and report information about the race and ethnicity of their patients and to assess how well these data are integ... At the time of our analysis, the National COVID Cohort Collaborative (N3C) Data Enclave contained records from 6.5 million patients contributed by 56 health care institutions. We quantified the variab... "No matching concept" was the second largest harmonized concept used by the N3C to describe the race of patients in their database. In addition, 20.7% of the race data did not conform to the standard;... Differences in how race and ethnicity data are conceptualized and encoded by health care institutions can affect the quality of the data in aggregated clinical databases. The impact of data quality is...

Developing Clinical Prediction Models Using Primary Care Electronic Health Record Data: The Impact of Data Preparation Choices on Model Performance.

To quantify prediction model performance in relation to data preparation choices when using electronic health records (EHR).... Cox proportional hazards models were developed for predicting the first-ever main adverse cardiovascular events using Dutch primary care EHR data. The reference model was based on a 1-year run-in peri... We included 89,491 patients in whom 6,736 first-ever main adverse cardiovascular events occurred during a median follow-up of 8 years. Outcome definition based only on diagnosis codes led to a systema... Data preparation choices regarding outcome definition or methods to address missing values can have a substantial impact on the calibration of predictions, hampering reliable clinical decision support...

Solving poverty or tackling healthcare inequalities? Qualitative study exploring local interpretations of national policy on health inequalities under new NHS reforms in England.

Major reforms to the organisation of the National Health Service (NHS) in England established 42 integrated care systems (ICSs) to plan and coordinate local services. The changes are based on the idea... We carried out qualitative research based on semistructured interviews with NHS, public health, social care and other leaders in three ICSs in England.... We selected three ICSs with varied characteristics all experiencing high levels of socioeconomic deprivation. We conducted 32 in-depth interviews with senior leaders of NHS, local government and other... Local interpretations of national policy objectives on health inequalities varied, and local leaders had contrasting-sometimes conflicting-perceptions of the boundaries of ICS action on reducing healt... Varied and vague interpretations of NHS policy on health inequalities are not new, but lack of clarity among local health leaders brings major risks-including interventions being poorly targeted or in...

Performance of ChatGPT as an AI-assisted decision support tool in medicine: a proof-of-concept study for interpreting symptoms and management of common cardiac conditions (AMSTELHEART-2).

It is thought that ChatGPT, an advanced language model developed by OpenAI, may in the future serve as an AI-assisted decision support tool in medicine.... To evaluate the accuracy of ChatGPT's recommendations on medical questions related to common cardiac symptoms or conditions.... We tested ChatGPT's ability to address medical questions in two ways. First, we assessed its accuracy in correctly answering cardiovascular trivia questions (... We found that ChatGPT latest version correctly answered 92% of the trivia questions, with slight variation in accuracy in the domains coronary artery disease (100%), pulmonary and venous thrombotic em... Our study suggests that ChatGPT has potential as an AI-assisted decision support tool in medicine, particularly for straightforward, low-complex medical questions, but further research is needed to fu...